Use of β-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands

por de Vries, F., Souverein, P. C., Cooper, C., Leufkens, H. G. M., van Staa, T. P.
Publicado 2007

Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study

por Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., de Vries, F.
Publicado 2010

Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest: rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registry

por Blom, M T, van Hoeijen, D A, Bardai, A, Berdowski, J, Souverein, P C, De Bruin, M L, Koster, R W, de Boer, A, Tan, H L
Publicado 2014

Risk of infections in patients with gout: a population-based cohort study

por Spaetgens, B., de Vries, F., Driessen, J. H. M., Leufkens, H. G., Souverein, P. C., Boonen, A., van der Meer, J. W. M., Joosten, L. A. B.
Publicado 2017

The risk of new fragility fractures in patients with chronic kidney disease and hip fracture—a population-based cohort study in the UK

por de Bruin, I.J.A., Wyers, C.E., Souverein, P.C., van Staa, T.P., Geusens, P.P.M.M., van den Bergh, J.P.W., de Vries, F., Driessen, J.H.M.
Publicado 2020

Long-term persistence with anti-osteoporosis drugs after fracture

por Klop, C., Welsing, P. M. J., Elders, P. J. M., Overbeek, J. A., Souverein, P. C., Burden, A. M., van Onzenoort, H. A. W., Leufkens, H. G. M., Bijlsma, J. W. J., de Vries, F.
Publicado 2015

Association of polymorphisms in the beta-2 adrenergic receptor gene with fracture risk and bone mineral density

por Veldhuis-Vlug, A. G., Oei, L., Souverein, P. C., Tanck, M. W. T., Rivadeneira, F., Zillikens, M. C., Kamphuisen, P. W., Maitland - van der Zee, A.H., de Groot, M. C. H., Hofman, A., Uitterlinden, A. G., Fliers, E., de Boer, A., Bisschop, P. H.
Publicado 2015